A RCT about amylin analog pramlintide showed the association between glycemic control and reduced psychological distress, and the authors concluded that “the difference between treatment arms in reduction of diabetes-related distress can be attributed to the differential impact of treatment on glucose control” [16]. Here, IAPP is linked to diabetes mellitus.